Stone Capital Partners Biosyngen to Setup US$50 Million Biopharmaceutical Investment Fund in Singapore – PRNewswire
Stone Capital Partners Biosyngen to Setup US$50 Million Biopharmaceutical Investment Fund in Singapore PRNewswire
Source: Investment New Feed